Agape ATP Corp Form 8-K Summary
Business Context and Reporting Period
Agape ATP Corp (NASDAQ: ATPC), a Nevada corporation headquartered in Kuala Lumpur, Malaysia, filed this Current Report on Form 8-K on March 12, 2026. The report addresses the status of the Company's listing on the Nasdaq Capital Market following a series of compliance notifications regarding its stock price.
Key Financial Metrics
This filing is a notice of delisting status and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event reported is the resolution of a delisting threat:
- Initial Non-Compliance: On January 27, 2026, Nasdaq notified the Company of non-compliance with the Minimum Bid Requirement (Rule 5550(a)(2)) due to a closing bid price below $1.00 for 30 consecutive days.
- Delisting Determination: On February 2, 2026, Nasdaq determined to delist the Company's securities under the "Low Priced Stocks" Rule (Rule 5810(c)(3)(A)(iii)) because the closing bid was $0.10 or less for ten consecutive trading days as of January 30, 2026.
- Regained Compliance: On March 10, 2026, the Company received confirmation from the Nasdaq Hearings Advisor that it has regained compliance with the bid price requirement.
- Outcome: The hearing scheduled for March 17, 2026, was cancelled, and the Company's Common Stock will continue to be listed and traded on the Nasdaq Stock Market.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of financial risks beyond the immediate listing status. The primary risk addressed was the potential delisting from Nasdaq, which has been temporarily resolved as of the report date.
Investor Verification Checklist
- Verify the current trading price of ATPC to ensure it remains above the $1.00 minimum bid requirement to prevent future delisting notices.
- Review the attached Press Release (Exhibit 99.1) for any additional details on the Company's strategy to maintain stock price compliance.
- Monitor future 8-K filings for any recurrence of non-compliance with Nasdaq Listing Rules.
- Confirm the Company's financial health through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.